why choose us

First received: April 15, 2025

Clinical Trial: HS-IT101 Injection in the Treatment of Advanced Melanoma(FASTIL-Mela01)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Melanoma

Study Type: INTERVENTIONAL


Official Title: Single Arm, Phase I Clinical Study of HS-IT101 Injection in the Treatment of Advanced Melanoma

Brief Summary: Single-arm, open-label,interventional study evaluating adoptive cell therapy (ACT) with autologous tumor-infiltrating lymphocyte (TIL) infusion (HS-IT101) after lymphodepletion preparative with fludarabine and cyclophosphamide regimen, followed by IL-2, for the treatment of patients with advanced melanoma.

Read more